Multi-Phase, Contrast-Enhanced Computed Tomography-Based Radiomic Prognostic Marker of Non-Metastatic Pancreatic Ductal Adenocarcinoma.
Dong Woo ShinJaewon ParkJong-Chan LeeYong-Tae KimYoung Hoon KimJin-Hyeok HwangPublished in: Cancers (2022)
Intra-tumoral contrast enhancement on CT is an independent prognostic factor in patients with non-metastatic PDA.